BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 22783696)

  • 1. Pelvic exenteration for locally advanced rectal carcinoma: factors predicting improved survival.
    Meterissian SH; Skibber JM; Giacco GG; el-Naggar AK; Hess KR; Rich TA
    Surgery; 1997 May; 121(5):479-87. PubMed ID: 9142144
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rectal adenocarcinoma: proposal for a model based on pretreatment prognostic factors.
    Cabanillas F; Nieves-Plaza M; Quevedo G; Echenique IA
    P R Health Sci J; 2012 Jun; 31(2):52-8. PubMed ID: 22783696
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Refining the Use of Adjuvant Oxaliplatin in Clinical Stage II or III Rectal Adenocarcinoma.
    Margalit O; Mamtani R; Kopetz S; Yang YX; Lawrence YR; Abu-Gazala S; Reiss KA; Golan T; Halpern N; Aderka D; Giantonio B; Shacham-Shmueli E; Boursi B
    Oncologist; 2019 Aug; 24(8):e671-e676. PubMed ID: 30696723
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Efficacy analysis of radiotherapy combined with surgery for locally advanced rectal mucinous adenocarcinoma: a retrospective study based on data of Surveillance, Epidemiology, and End results population].
    Zhang Y; Wang X; Chi P; Lin H; Lu X; Huang Y; Xu Z; Huang S; Sun Y; Ye D
    Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Jan; 22(1):85-93. PubMed ID: 30703799
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Elevated preoperative CEA is associated with worse survival in stage I-III rectal cancer patients.
    Tarantino I; Warschkow R; Worni M; Merati-Kashani K; Köberle D; Schmied BM; Müller SA; Steffen T; Cerny T; Güller U
    Br J Cancer; 2012 Jul; 107(2):266-74. PubMed ID: 22735902
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association between smoking at diagnosis and cause-specific survival in patients with rectal cancer: Results from a population-based analysis of 10,794 cases.
    Sharp L; McDevitt J; Brown C; Carsin AE; Comber H
    Cancer; 2017 Jul; 123(13):2543-2550. PubMed ID: 28297071
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fluorouracil-based adjuvant chemotherapy after preoperative chemoradiotherapy in rectal cancer: long-term results of the EORTC 22921 randomised study.
    Bosset JF; Calais G; Mineur L; Maingon P; Stojanovic-Rundic S; Bensadoun RJ; Bardet E; Beny A; Ollier JC; Bolla M; Marchal D; Van Laethem JL; Klein V; Giralt J; Clavère P; Glanzmann C; Cellier P; Collette L;
    Lancet Oncol; 2014 Feb; 15(2):184-90. PubMed ID: 24440473
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preoperative irradiation and surgery for local recurrence of rectal and rectosigmoid cancer. Prognostic factors with regard to survival and further local recurrence.
    Wiig JN; Larsen SG; Dueland S; Giercksky KE
    Colorectal Dis; 2008 Jan; 10(1):48-57. PubMed ID: 18028472
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Patients with curative resection of cT3-4 rectal cancer after preoperative radiotherapy or radiochemotherapy: does anybody benefit from adjuvant fluorouracil-based chemotherapy? A trial of the European Organisation for Research and Treatment of Cancer Radiation Oncology Group.
    Collette L; Bosset JF; den Dulk M; Nguyen F; Mineur L; Maingon P; Radosevic-Jelic L; Piérart M; Calais G;
    J Clin Oncol; 2007 Oct; 25(28):4379-86. PubMed ID: 17906203
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preoperative radiotherapy with or without concurrent fluorouracil and leucovorin in T3-4 rectal cancers: results of FFCD 9203.
    Gérard JP; Conroy T; Bonnetain F; Bouché O; Chapet O; Closon-Dejardin MT; Untereiner M; Leduc B; Francois E; Maurel J; Seitz JF; Buecher B; Mackiewicz R; Ducreux M; Bedenne L
    J Clin Oncol; 2006 Oct; 24(28):4620-5. PubMed ID: 17008704
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preoperative carcinoembryonic antigen and albumin in predicting survival in patients with colon and rectal carcinomas.
    Boonpipattanapong T; Chewatanakornkul S
    J Clin Gastroenterol; 2006 Aug; 40(7):592-5. PubMed ID: 16917399
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A pathologic complete response of rectal cancer to preoperative combined-modality therapy results in improved oncological outcome compared with those who achieve no downstaging on the basis of preoperative endorectal ultrasonography.
    Stipa F; Chessin DB; Shia J; Paty PB; Weiser M; Temple LK; Minsky BD; Wong WD; Guillem JG
    Ann Surg Oncol; 2006 Aug; 13(8):1047-53. PubMed ID: 16865595
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improved incidence of pT0 downstaged surgical specimens in locally advanced rectal cancer (LARC) treated with induction oxaliplatin plus 5-fluorouracil and preoperative chemoradiation.
    Calvo FA; Serrano FJ; Diaz-González JA; Gomez-Espi M; Lozano E; Garcia R; de la Mata D; Arranz JA; García-Alfonso P; Pérez-Manga G; Alvarez E
    Ann Oncol; 2006 Jul; 17(7):1103-10. PubMed ID: 16670204
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The influence of the surgeon's and the hospital's caseload on survival and local recurrence after colorectal cancer surgery.
    Renzulli P; Lowy A; Maibach R; Egeli RA; Metzger U; Laffer UT
    Surgery; 2006 Mar; 139(3):296-304. PubMed ID: 16546492
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.